To inform practice of histologic T cell biomarker interpretation, we examined step sections of breast and colorectal cancer samples for CD8 T cell prevalence by immunohistochemistry, and performed in silico biopsy sampling of these sections to determine CD8 variability within a tumor block and between simulated biopsy samples. This evidence concerns the gene CD8A and neoplasm.